<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362537">
  <stage>Registered</stage>
  <submitdate>23/05/2012</submitdate>
  <approvaldate>24/05/2012</approvaldate>
  <actrnumber>ACTRN12612000552886</actrnumber>
  <trial_identification>
    <studytitle>Coenzyme Q10 for Alleviation of the Fatigue of Post Polio Syndrome</studytitle>
    <scientifictitle>Oral supplementation of polio survivors with Post Polio Syndrome or Late Effects of Polio by coenzyme Q10 for relief of their excessive fatigue, as measured by fatigue questionnaires.</scientifictitle>
    <utrn>Nil</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Excessive fatigue symptom of Post Polio Syndrome/Late Effects of Polio</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Oral supplementation by 100 mg capsule of CoQ10 daily for a period of 2 months</interventions>
    <comparator>Placebo of oil capsule which is taken daily for a period of 2 months</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>A statistically significant reduction in fatigue levels in the CoQ10 intervention group as compared to the placebo group, as assessed by the Fatigue Severity Scale (FSS) and the Multidimensional Assessment of Fatigue (MAF) Scale.</outcome>
      <timepoint>Two months after randomisation.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Polio survivors with Post Polio Syndrome or the Late Effects of Polio who attribute their excessive fatigue primarily to PPS/LEOP</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Diagnosis with another medical condition that may account for the excessive fatigue, e.g. diabetes, anaemia, thyroid deficiency or fibromyalgia.
Treatment with warfarin since CoQ10 can redcue its effectiveness.
Those already taking CoQ10 on a regular basis</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subjects will be enrolled into the study and allocated to the intervention and placebo groups by the automated randomisation service of the Griffith Clinical Trials Unit. Those who use energy-saving, motorised wheelchairs or scooters solely or mainly for mobility will be randomly equally distributed to the intervention and placebo groups to prevent bias (stratified randomisation).</concealment>
    <sequence>By an automated, random-order, computer-generated program at the Griffith Clinical Trials Unit.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>1/09/2012</anticipatedstartdate>
    <actualstartdate>6/11/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate>9/09/2013</actualenddate>
    <samplesize>110</samplesize>
    <actualsamplesize>103</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,QLD</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Professor Marie Cooke</primarysponsorname>
    <primarysponsoraddress>School of Nusring and Midwifery
Griffith University
Nathan Campus
Kessels Road
Nathan
QLD 4111</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Cancer and Polio Research Fund</fundingname>
      <fundingaddress>Newell Lane
Hoylake
Wirral CH47 4BQ</fundingaddress>
      <fundingcountry>United Kingdom</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Professor Wendy Moyle</sponsorname>
      <sponsoraddress>Director, Centre for Clinical and Community Innovation
School of Nursing and Midwifery
Griffith University
Nathan Campus
Kessels Road 
Nathan
QLD 4111</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of the clinical trial is to determine whether taking a 100 mg capsule of coenzyme Q10 daily for a period of two months can alleviate the excessive fatigue of Post Polio Syndrome or Late Effects of Polio.  This will be tested in a randomised, double-blind, placebo-controlled trial at the Griffith Clinical Trials Unit.  Fatigue will be assessed by two fatigue questionnaires to be filled out by the participants before the start of the trial (baseline) and after the two-month period of taking capsules. Coenzyme Q10 blood levels will also be determined to confirm compliance and to validate the findings. Statistical analysis of the questionnaires will be undertaken by a biostatistician.</summary>
    <trialwebsite />
    <publication>Manuscript now accepted 
MM Peel, M Cooke, HJ Lewis-Peel, RA Lea, W Moyle (2015). . Investigation of the alleviation of fatigue of the late-onset sequelae of poliomyelitis by coenzyme Q10: a randomised, double-blind, placebo-controlled trial. 
Complementary Therapies in Medicine 23 (6), 789-793
http://dx.doi.org/10.1016/j.ctim.2015.09.002</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Griffith University HREC</ethicname>
      <ethicaddress />
      <ethicapprovaldate>9/07/2012</ethicapprovaldate>
      <hrec>NRS/20/12/HREC</hrec>
      <ethicsubmitdate>25/05/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Professor Marie Cooke</name>
      <address>Professor of Nursing
School of Nursing and Midwifery
Griffith University
Nathan Campus
Kessels Road
Nathan
QLD 4111</address>
      <phone>+61 7 3735 5253</phone>
      <fax>+61 7 3735 5431</fax>
      <email>m.cooke@griffith.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Professor Marie Cooke</name>
      <address>Professor of Nursing
School of Nursing and Midwifery
Griffith University
Nathan Campus
Kessels Road
Nathan
QLD 4111</address>
      <phone>+61 7 3735 5253</phone>
      <fax>+61 7 3735 5431</fax>
      <email>m.cooke@griffith.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Marie Cooke</name>
      <address>Professor of Nursing
School of Nursing and Midwifery
Griffith University
Nathan Campus
Kessels Road
Nathan
QLD 4111</address>
      <phone>+61 7 3735 5253</phone>
      <fax>+61 7 3735 5431</fax>
      <email>m.cooke@griffith.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Margaret Peel</name>
      <address>C/- Marie Cooke
Griffith University
N48_2.21
170 Kessels Road
Nathan Qld 4111</address>
      <phone>+61 07 32646783</phone>
      <fax />
      <email>mmp27@aapt.net.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>